Tate Jeffrey's Form 4 filing
Cyclo Therapeutics, Inc. (CYTH) · filed Apr 24, 2023
- Accession no.
- 0001437749-23-010879
- Filed
- Apr 24, 2023, 11:00 AM ET
- Trade date
- Apr 20, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $21.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tate JeffreyCIK 0001499075 | Director, Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 20, 2023 | Common Stock | PPurchaseAcquired | +29,941 | $0.71 | +$21,258.11 | 62,101 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 20, 2023 | Common Stock | PPurchaseAcquired | +29,941 | $0.125 | +$3,742.63 | 29,941 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.